-- Introduction:
Conjunctivitis or pink eye is an inflammation or redness of the lining of the white part of the eye and the underside of the eyelid that can be caused by infection, allergic reaction, or physical agents like infrared or ultraviolet light.
Do Inquiry Before Purchasing Report Here: https://market.biz/report/global-conjunctivitis-market-gm/101663/#inquiry
The Global Conjunctivitis Market is projected to grow with a CAGR between 2.1% and 2.5% during 2016-2022 and reach USD X.XX billion by 2022. Conjunctivitis or pink eye is an inflammation or redness of the lining of the white part of the eye and the underside of the eyelid that can be caused by infection, allergic reaction, or physical agents like infrared or ultraviolet light. Conjunctivitis is an extremely common eye problem because the conjunctiva is continually exposed to microorganisms and environmental agents that can cause infections or allergic reactions. It can also affect one or both eyes and, if caused by infection, can be very easily transmitted to others during close physical contact, particularly among children in a daycare center. Thus, people diagnosed with conjunctivitis are recommended not to travel public places for that period of time.
Segments Covered:
The report segments the conjunctivitis market by disease type and by region. Market segmentation based on disease type includes Bacterial conjunctivitis, viral conjunctivitis and Allergic conjunctivitis. Furthermore, Allergic conjunctivitis segment is anticipated to grow at the highest CAGR over the forecast period accounted for more than 45% of the total market share by 2022. The key factor driving the growth of allergic conjunctivitis segment, are considered to be the different allergies present in the environment such as cold, acute respiratory infection, or other diseases such as measles, herpes simplex , or herpes zoster.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America along with Latin America accounted for the largest market share together occupying more than 50% share of global market and is expected to continue its dominance over the forecast period. Increasing awareness among the patient and availability of multiple treatment options are expected to drive the growth in this region. Moreover, Asia Pacific is anticipated to grow at the highest CAGR over the forecast period and provides the opportunity for market growth due to presence of major players and increasing R&D activities.
The companies covered in the Global Conjunctivitis Market report:
• Akorn
• Alcon
• Allergan, Inc.
• Bausch & Lomb
• Celsus Therapeutics
• Eleven Biotherapeutics
• Griffin Discoveries
• InSiteVision
• Merck
• Nicox
• NovaBay
• Ocular Therapeutix
• Santen Pharmaceutical
• Starpharma
• Sun Pharma
• Pfizer, Inc.
Request For Sample Report Here: https://market.biz/report/global-conjunctivitis-market-gm/101663/#requestforsample
About Us:
Market.Biz consists of a highly motivated team of young and experienced individuals who are detail-oriented and highly focused on providing clients with the information they need. Information is king in the business world, and we specialize in providing that.
Referal News Network: http://peopleexclusive.com/
Contact Info:
Name: Lawrence John
Email: Send Email
Organization: Market.Biz
Address: S no. 51/14 First Floor, Office Number 4, Vishwa Arcade, Near Navale Lawns, Pune, Maharashtra, India 411041.
Phone: +1(857)2390696
Website: https://market.biz/report/global-conjunctivitis-market-gm/101663/
Release ID: 214816
Google
RSS